Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.
2.
3.

State of the art and future prospects in the management of neuroendocrine tumors.

Oberg K.

Q J Nucl Med. 2000 Mar;44(1):3-12. Review.

PMID:
10932597
4.

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.

Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.

Hepatogastroenterology. 2005 May-Jun;52(63):731-41.

PMID:
15966194
5.

Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.

Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP.

Gastroenterology. 2010 Sep;139(3):742-53, 753.e1. doi: 10.1053/j.gastro.2010.07.002. Epub 2010 Jul 13. Review.

PMID:
20637207
6.

Molecular genetics of gastroenteropancreatic neuroendocrine tumors.

Starker LF, Carling T.

Curr Opin Oncol. 2009 Jan;21(1):29-33. doi: 10.1097/CCO.0b013e328319ea7b. Review.

PMID:
19125015
7.

Diagnosis and management of gastrointestinal neuroendocrine tumors.

Modlin IM, Basson MD, Mani S.

Gastroenterologist. 1993 Mar;1(1):59-70. Review.

PMID:
8049881
8.
9.

[The somatostatin receptor family--a window against new diagnosis and therapy of cancer].

Hofsli E.

Tidsskr Nor Laegeforen. 2002 Feb 20;122(5):487-91. Review. Norwegian.

PMID:
11961977
10.

Endocrine tumors of the gastrointestinal tract.

Haller DG.

Curr Opin Oncol. 1994 Jan;6(1):72-6. Review.

PMID:
8204694
11.

New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.

Pape UF, Höcker M, Seuss U, Wiedenmann B.

Recent Results Cancer Res. 2000;153:45-60. Review.

PMID:
10626288
12.

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.

Turaga KK, Kvols LK.

CA Cancer J Clin. 2011 Mar-Apr;61(2):113-32. doi: 10.3322/caac.20097.

13.

An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.

Chetty R.

Arch Pathol Lab Med. 2008 Aug;132(8):1285-9. doi: 10.1043/1543-2165(2008)132[1285:AOOPII]2.0.CO;2. Review.

PMID:
18684027
14.

The expression of NeuroD and mASH1 in the gastroenteropancreatic neuroendocrine tumors.

Shida T, Furuya M, Kishimoto T, Nikaido T, Tanizawa T, Koda K, Oda K, Takano S, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Nakatani Y, Miyazaki M.

Mod Pathol. 2008 Nov;21(11):1363-70. doi: 10.1038/modpathol.2008.121. Epub 2008 Jun 27.

15.

[Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].

Bodelier AG, Haak HR.

Ned Tijdschr Geneeskd. 2006 Aug 26;150(34):1868-72. Review. Dutch.

PMID:
16970007
16.

Advances in chemotherapy and biotherapy of endocrine tumors.

Oberg K.

Curr Opin Oncol. 1998 Jan;10(1):58-65. Review.

PMID:
9466486
17.

Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.

Goldin SB, Aston J, Wahi MM.

Curr Opin Oncol. 2008 Jan;20(1):25-33. Review.

PMID:
18043253
18.

Current knowledge on diagnosis and staging of neuroendocrine tumors.

Oberg K, Castellano D.

Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:3-7. doi: 10.1007/s10555-011-9292-1. Review.

PMID:
21311954
19.

[New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].

Rubello D, Rufini V, De Carlo E, Martini C, Calcagni ML, Sicolo N, Troncone L, Casara D.

Minerva Endocrinol. 2003 Dec;28(4):259-96. Review. Italian.

PMID:
14752399
20.

Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.

Pelley RJ, Bukowski RM.

Curr Opin Oncol. 1997 Jan;9(1):68-74. Review.

PMID:
9090496

Supplemental Content

Support Center